1. A Novel Hydroxamic Acid-Based Curcumin Derivative as Potent Histone Deacetylase Inhibitor for the Treatment of Glioblastoma
   Hao Wang et al, 2021, Frontiers in Oncology CrossRef
2. Effects of tubastatin A on adrenocorticotropic hormone synthesis and proliferation of AtT-20 corticotroph tumor cells
   Rie Hagiwara et al, 2022, Endocrine Journal CrossRef
3. Glioblastoma: Current Status, Emerging Targets, and Recent Advances
   Amandeep Thakur et al, 2022, Journal of Medicinal Chemistry CrossRef
4. The application of histone deacetylases inhibitors in glioblastoma
   Rui Chen et al, 2020, Journal of Experimental & Clinical Cancer Research CrossRef
5. A Review of Progress in Histone Deacetylase 6 Inhibitors Research: Structural Specificity and Functional Diversity
   Xin-Hui Zhang et al, 2021, Journal of Medicinal Chemistry CrossRef
6. Primary Cilia–Related Pathways Moderate the Development and Therapy Resistance of Glioblastoma
   Minghao Li et al, 2021, Frontiers in Oncology CrossRef
7. A novel cuproptosis-related lncRNA signature predicts the prognosis and immune landscape in bladder cancer
   Yuchen Bai et al, 2022, Frontiers in Immunology CrossRef
8. Recent histone deacetylase inhibitors in cancer therapy
   Roza Parveen et al, 2023, Cancer CrossRef
9. Small Molecules Targeting HATs, HDACs, and BRDs in Cancer Therapy
   Donglu Wu et al, 2020, Frontiers in Oncology CrossRef
10. Recent advances in the understanding of cilia mechanisms and their applications as therapeutic targets
    Masaki Saito et al, 2023, Frontiers in Molecular Biosciences CrossRef
11. Treatment of Toxoplasmosis: An Insight on Epigenetic Drugs
    Paolo Guglielmi et al, 2022, Antiprotozoal Drug Development and Delivery CrossRef